Mark Warner interviewed on the Ryan Jespersen Show on AM630 CHED in Edmonton about the status of the Trans-Pacific Partnership (TPP) trade negotiations, including agriculture and supply management, and autos and auto parts rules of origin. (August 26, 2015) [Listen from 9:16 to 22:52]
Mark Warner is quoted in this Canadian Bar Association National Magazine article about Sticking Points in the Trans-Pacific Partnership (TPP) Agreement negotiations, including pharmaceuticals and state-owned enterprises (SOEs). (August 21, 2015)
Mark Warner lectured on Competition, Trade & Investment Issues Affecting the Pharmaceutical Industry at the Rutgers Institute for Information Policy and Law. (April 9, 2015) Mr. Warner discussed: the Canadian Competition Bureau approach to patent litigation “pay for delay” settlement agreements; Eli Lilly’s $500 million North American Trade Agreement (NAFTA) Chapter 11 investor-state arbitration claiming that Canadian patent laws unfairly discriminate against pharmaceutical companies; and pharmaceutical issues in the Canada-European Union Trade Agreement (CETA) and Trans-Pacific Partnership Agreement (TPP) negotiations. Mr. Warner was Legal Director of the Ontario Ministry of Economic Development & Trade and advised Ontario in the CETA negotiations and on several NAFTA Chapter 11 Investor-State Arbitrations. Mr. Warner, a Canadian and U.S. lawyer, has advised governments on trade policy and trade negotiations and previously worked on trade and competition issues as counsel in the OECD Trade Directorate.
